Bartlett & Co. LLC Cti Biopharma Corp Transaction History

Bartlett & Co. LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 17, 2022	BUY	$5.36 - $7.43 $198,518 - $275,184	37,037 New	37,037 $216,000
Q2 2022 Aug 02, 2022	SELL	$3.55 - $6.27 $129,575 - $228,854	-36,500 Closed	0 $0
Q4 2021 Mar 08, 2022	BUY	$1.44 - $2.86 $52,560 - $104,390	36,500 New	36,500 $91,000

Ticker CTIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,385,000
Market Cap $1.04B
Description
CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...

Get notified when there are updates to the investment portfolio of Bartlett & Co. LLC, based on Form 13F filings with the SEC.

Stay updated on Bartlett & Co. LLC with notifications on news.